# Safety and Protective Efficacy of BCG Vaccination Against Controlled Human Malaria Infection

> **NCT02692963** · PHASE2 · COMPLETED · sponsor: **Radboud University Medical Center** · enrollment: 20 (actual)

## Conditions studied

- Malaria
- Plasmodium Falciparum

## Interventions

- **BIOLOGICAL:** BCG vaccination

## Key facts

- **NCT ID:** NCT02692963
- **Lead sponsor:** Radboud University Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-04
- **Primary completion:** 2016-10
- **Final completion:** 2017-02
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2017-04-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02692963

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02692963, "Safety and Protective Efficacy of BCG Vaccination Against Controlled Human Malaria Infection". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02692963. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*